The randomized Phase 2 trial enrolled 338 adults and compared several retatrutide groups with placebo. At week 48 the 12 mg group had an estimated mean weight change of −24.2%, compared with −2.1% with placebo.
48-week group averages
The 48-week result was a secondary time point. The primary outcome was percentage change in body weight at 24 weeks. Put the week number next to the percentage whenever quoting it.
How to interpret the evidence
Group averages summarize a distribution of responses. Read the adverse-event results and the analysis definition alongside the weight estimate.
When comparing results, record the primary outcome, the measurement week, and whether the analysis included outcomes after treatment stopped.